Home NDC 70518-4571-2 buprenorphine hydrochloride
Product NDC 70518-4571
Requested package NDC 70518-4571-2
11-digit product format 705184571
Labeler code 70518
Product ID 70518-4571_4a90c80f-32a9-ea0d-e063-6394a90aae6e
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name buprenorphine hydrochloride
Dosage form TABLET
Route SUBLINGUAL
Labeler REMEDYREPACK INC.
Application ANDA090622
Marketing category ANDA
Marketing start 2026-02-10
Substance BUPRENORPHINE HYDROCHLORIDE
Active strength 8 mg/1
Pharmacologic classes Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA]
DEA schedule CIII
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090622-001 BUPRENORPHINE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 A090622-002 BUPRENORPHINE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A090622-001 BUPRENORPHINE HYDROCHLORIDE EQ 2MG BASE TABLET / SUBLINGUAL AB 2010-09-24 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A090622-002 BUPRENORPHINE HYDROCHLORIDE EQ 8MG BASE TABLET / SUBLINGUAL AB 2010-09-24 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
Additional Listing Data#
Finished product Yes
Brand name base buprenorphine hydrochloride
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength BUPRENORPHINE HYDROCHLORIDE 8 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 56W8MW3EN1 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 351265 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70518-4571-0 buprenorphine hydrochloride 30 in 1 BOX TABLET 30 1 70518-4571-1 buprenorphine hydrochloride 1 in 1 POUCH TABLET 1 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Status 70518-4571-2 70518457102 50 POUCH in 1 BOX (70518-4571-2) / 1 TABLET in 1 POUCH (70518-4571-1) 50 pouch 2026-07-07 0 Current